Covid-19 in Lupus Nephritis

    Ramadhan Ananda Putra, Raveinal, Fauzar, Deka Viotra
    Image of study
    TLDR Patients with lupus nephritis and COVID-19 can improve with proper treatment.
    The document discussed the management of COVID-19 in patients with systemic lupus erythematosus (SLE), highlighting the increased risk of severe infection due to immunosuppressive drug use and the autoimmune nature of the disease. It presented a case of a patient with SLE, lupus nephritis, and other complications who was treated with methylprednisolone and hydroxychloroquine for SLE, and azithromycin plus oseltamivir for COVID-19. The patient showed clinical improvement and was discharged after 24 days of hospitalization with negative RT-PCR results. The document noted that hydroxychloroquine had a beneficial effect on SARS-CoV-2 in patients with SLE who took the medication regularly.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results